HomeAI · summaries
Storia in 18 fonti
GSK compra Nuvalent por US$ 10,6 bilhões e amplia aposta em oncologia
A aquisição deve dar à GSK a propriedade de três medicamentos candidatos para o tratamento de câncer de pulmão
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.
- ·
handelsblatt.com
Nuvalent: GSK übernimmt Krebsspezialisten für 10,6 Milliarden Dollar
Der britische Pharmariese will mit der Übernahme des US-Biotechs sein Onkologie-Portfolio ausbauen. Es wäre ein früher Erfolg des neuen Konzernchefs Miels.
